CAMBRIDGE, Mass.--(BUSINESS WIRE)--GenePeeks, Inc., a computational genomics company focused on transforming genetic disease risk analysis, today announced partnerships with two leading fertility organizations: The Donor Solution, an independent egg donation agency, and 3 Sisters Surrogacy, a gestational carrier service.
Through these partnerships, more prospective parents will have access to GenePeeks’ proprietary preconception genetic screening test, which assesses combined parental risk of passing on more than 1,000 serious genetic diseases. GenePeeks’ comprehensive approach, called Virtual Progeny Analytics (VPA), uniquely integrates simulated DNA information from two genetic participants to predict the future genome of a child prior to conception. For every mutation in these hypothetical genomes, the company computes a proprietary Variant Gene Dysfunction (VGD) score that predicts gene function and associated disease risk. This next generation approach allows GenePeeks to cover an expanded number of diseases with increased sensitivity and evaluate variants that may remain uncharacterized by other genetic tests, while avoiding the confusion and anxiety that can be associated with carrier testing. In contrast to carrier screening, which identifies parental carrier status, GenePeeks focuses on a future child’s true risk of disease inheritance. GenePeeks offers this physician-ordered service through its CLIA certified clinical laboratory.
Over the last ten years, The Donor Solution has helped over 1,000 families to have children, with a success rate of over 82% for first time donors. 3 Sisters Surrogacy provides exceptional support for the increasing number of individuals seeking a gestational carrier to build their family. Clients using the services of either agency will be able to use the GenePeeks test to make more informed reproductive decisions with increased confidence. In addition, The Donor Solution’s donors who have completed the pre-test protocols will be identified as “GenePeeks Ready,” saving prospective parents precious time in their fertility journey.
“We are thrilled to partner with The Donor Solution and 3 Sisters Surrogacy, two organizations that share our unrelenting commitment to provide outstanding support on the complicated path of starting a family,” said Anne Morriss, Co-founder and Chief Executive Officer of GenePeeks. “In addition to reaching more families, these collaborations will allow us to expand our physician network and increase patient access to our next generation technology.”
Mary Fusillo, Founder and Executive Director of The Donor Solution and Chief Executive Officer of 3 Sisters Surrogacy, stated, “At The Donor Solution and 3 Sisters Surrogacy, we are committed to providing our clients with the highest quality care possible. Our partnership with GenePeeks is an important step in ensuring that our intended families can protect the future health of their children with access to the most advanced preconception risk screening available.”
GenePeeks is a computational genomics company focused on identifying inherited disease risk in future generations. GenePeeks’ patented technology digitally combines the genetic information of two potential parents, simulating the complex genetic interactions that occur naturally in human reproduction. The company’s proprietary platform creates and analyzes thousands of Virtual Progeny to uncover disease risk that cannot be seen with alternative screening tools. GenePeeks offers this physician-ordered service through its CLIA certified clinical laboratory.
GenePeeks is privately held, with corporate offices in Cambridge, Mass. For more information, visit www.genepeeks.com.
GenePeeks’ next-generation screening technology is available today. For more information about becoming a partner, please contact email@example.com.
About The Donor Solution
The Donor Solution is a leading egg donor agency in the southwest United States. Known for providing exceptional egg donors, the agency recruits outstanding young women for their program. Founded in 2007 by Mary M. Fusillo, RN, BSN, MS, the agency has helped over 1,000 couples reach their goal of becoming parents. With over 25 years of nursing and hospital management experience, Mary and her team are committed to reducing the stress of the fertility journey while delivering the highest standard of care to both donors and recipients. The organization has offices in Houston and Dallas, Texas and Phoenix, Arizona, with satellite offices in Austin, Texas and Los Angeles/Beverly Hills, California. For more information, visit thedonorsolution.com.
About 3 Sisters Surrogacy
3 Sisters Surrogacy is a gestational carrier program dedicated to providing intended parents with the highest level of competence and professionalism. Chief Executive Officer Mary M. Fusillo, RN, BSN, MS has over 16 years of third party parenting experience and donor recruitment, and Chief Scientific Officer Sunday Crider, Ph.D., has worked for 13 years as an IVF embryologist and laboratory director. This combined experience is unique in the industry and has allowed the organization to provide the highest standard of service to all clients. Corporate offices are located in Houston, Texas, with satellite offices in Dallas, Texas and Phoenix, Arizona. For more information, visit 3sisterssurrogacy.com.